Kytopen Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Kytopen is a Cambridge-based biotechnology company focused on developing and commercializing genome engineering platforms to accelerate the discovery, development, and manufacture of gene-modified cell therapies. Its Flowfect platform integrates microfluidics and automation to deliver genome engineering materials to therapeutic cells, aiming for faster, scalable, and more cost-efficient workflows than current approaches. The technology originated at MIT, and in May 2023 the company introduced Flowfect Discover, an automated high-throughput system designed to support partners in early-stage development and manufacturing workflows. It has formed collaborations with contract development and manufacturing organizations and translational academic medical centers to advance its workflows. Recent developments include expanding partnerships into Europe with T-CURX GmbH and establishing a joint Center of Excellence with Fraunhofer IZI in Würzburg and Leipzig, Germany.